Danielle Kirsh
Senior Editor, Life Sciences at MassDevice
Senior Editor, Life Sciences at Medical Design & Outsourcing
Senior Editor, Life Sciences at WTWH Media LLC
Senior Editor, Life Sciences at Medical Tubing + Extrusion
Medtech journalist covering medical device news at @MassDevice & @MedTechDaily, part of the @WTWH_Media network | #WomeninMedtech | she/her
Articles
-
1 week ago |
massdevice.com | Danielle Kirsh
23andMe said it has reached a deal to sell its assets to a nonprofit led by company co-founder Anne Wojcicki. Wojcicki’s TTAM Research Institute offered $305 million for substantially all of 23andMe’s assets, including its consumer genetics and research services, as well as the Lemonaid Health telehealth business. The final round of bidding took place on June 13 under the supervision of the U.S. Bankruptcy Court for the Eastern District of Missouri.
-
1 week ago |
medicaldesignandoutsourcing.com | Danielle Kirsh
Researchers from the Singapore-MIT Alliance for Research and Technology (SMART) and KK Women’s and Children’s Hospital (KKH) have developed a first-of-its-kind device that profiles newborns’ immune function in under 15 minutes using only a drop of blood. The device, called BiophysicaL Immune Profiling for Infants (BLIPI), provides clinicians with real-time data to help detect life-threatening inflammatory conditions, such as sepsis and necrotizing enterocolitis (NEC).
-
1 week ago |
pharmaceuticalprocessingworld.com | Danielle Kirsh
Great Point Partners has acquired a majority stake in Eutecma, a Germany-based developer of reusable and modular temperature-controlled packaging for pharmaceutical cold chain logistics. The investment will support Eutecma’s global expansion strategy, particularly in the U.S. market, and bolster its efforts to reduce emissions and waste in drug shipping and storage. Eutecma supplies passive cooling systems for pharmaceutical, medical and diagnostic applications.
-
1 week ago |
massdevice.com | Danielle Kirsh
SS Innovations has announced the first robotic cardiac surgery performed in the Western Hemisphere using its SSi Mantra 3 surgical robotic system. Cardiothoracic surgeon Dr. Juan Zuniga performed the procedure, a robotic atrial septal defect closure, on June 8 at Interhospital in Guayaquil, Ecuador. According to the company, the successful operation marks a milestone and reflects its push to expand globally with a lower-cost alternative to existing systems.
-
2 weeks ago |
medicaltubingandextrusion.com | Danielle Kirsh
InspireMD today announced it received CE Mark approval for its CGuard Prime carotid stent system for the prevention of stroke. The Miami-based company said the next-generation carotid stent system was developed based on physician feedback and features improved deliverability and deployment. It builds on the original CGuard design, which uses a proprietary MicroNet mesh to reduce the risk of stroke by trapping embolic debris and preventing plaque prolapse.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 438
- Tweets
- 448
- DMs Open
- Yes
Today's episode of the @MassDevice Fast Five is live. We discussed #medtech news from @Nuwellis_Inc, @BDandCo, @CorWave, @AvanosMedical, @Surmodics, & @steris. Acquisitions & FDA approvals are top of the news today. Tune in wherever you listen to podcasts. https://t.co/Qv1ENV94tZ
Want to catch up on all the latest #medtech news from this week? Check out the @MassDevice Fast Five medtech news podcast. Head over to https://t.co/LvzYPTOBe6, or wherever you listen to podcasts, to hear the latest news in the industry. Subscribe and never miss a new episode. https://t.co/JptdZ8DvbY
Tune in to today's episode of the @MassDevice Fast Five #medtech news podcast. We discuss news from @endologix, @RelievantMed, @Masimo, @SiemensHealth, and @Philips. Click here for more insights into today's episode and to listen: https://t.co/kbtzg41NDs